Pharmacokinetically-guided on the Individualization of Pembrolizumab Administration in the Treatment of Lung Cancer
Clinical trial NCT05226728 · COMPLETED
Trial details
- NCT number
- NCT05226728
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-10
- Primary completion
- 2021-02-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.